You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

SARS-CoV-2

Test Information
Home / Tests / Critical Infectious Diseases / Xpert Xpress CoV-2/Flu/RSV plus

Xpert® Xpress CoV-2/Flu/RSV plus

Actionable, rapid respiratory results to meet the challenges of the ongoing pandemic

Xpert<sup>® </sup>Xpress CoV-2/Flu/RSV <em>plus</em>

The Need


  • Rapidly detect SARS-CoV-2, including emerging variants, to provide a timely, effective triage
  • Respiratory tract infections require an accurate diagnosis to ensure that patients receive appropriate treatment
  • Rapidly differentiate Flu A, Flu B, RSV, and COVID-19.  Identify potential cases of co-infections during respiratory season

The Solution


  • Actionable detection of SARS-CoV-2 in as little as 25 minutes, with results for all four pathogens in just 36 minutes
  • Robust design with three distinct gene targets for SARS-CoV-2:  N2, E, RdRP to offer broader coverage against mutations
  • Rapid sample to answer provides actionable results from a single sample with less than one minute of hands-on time
  • Standardization of results between the central lab and near-patient testing sites

The Impact


  • Ensures that patients receive appropriate treatment in a timely manner
  • Supports clinicians with broader coverage for variants
  • Single cartridge with an easy-to-use workflow, enabling hospitals to effectively manage limited resources

For Use Under an Emergency Use Authorization (EUA) only. This test has not been FDA cleared or approved; this test has been authorized by FDA under an EUA for use by authorized laboratories; this test has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acids from SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV), and not for any other viruses or pathogens; and this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

Full test runtime is 36 minutes. SARS-CoV-2 positive results available in as soon as 25 minutes with early assay termination.

Ordering Info


Xpert® Xpress CoV-2/Flu/RSV plus

Number of Tests: 10  

Catalog #: XP3COV2/FLU/RSV-10

Frequently Asked Questions

How is the Xpert Xpress CoV-2/Flu/RSV plus product different from the existing Xpert Xpress SARS-CoV-2/Flu/RSV product?

What sample types and collection devices can be used with Xpert Xpress CoV-2/Flu/RSV plus?

What are my options for Viral Transport Media for Xpert Xpress CoV-2/Flu/RSV plus?

What external quality control (QC) material options are available for Xpert Xpress CoV-2/Flu/RSV plus?

Back to Top